Now showing items 1-1 of 1

  • Faster access to new drugs: Fault lines between Health Canada’s regulatory intent and Industry innovation practices 

    Graham, J. E., & Nuttall, R. K. (2013). Faster access to new drugs: Fault lines between Health Canada’s regulatory intent and Industry innovation practices. Ethics in Biology, Engineering and Medicine: An International Journal, 4(3), 231-239. DOI: 10.1615/EthicsBiologyEngMed.2014010771.
    Since 2003, Health Canada has been undergoing regulatory modernization to “ensure that Canadians have faster access to the safe drugs they need.” As national health agencies develop policies to modernize the regulation ...